Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus.
Animals
CD8-Positive T-Lymphocytes
/ immunology
Cell Line
Dendritic Cells
/ immunology
Dogs
Female
Immunity, Innate
/ immunology
Influenza A virus
/ immunology
Interferon-gamma
/ immunology
Interleukin-10
/ immunology
Madin Darby Canine Kidney Cells
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Orthomyxoviridae Infections
/ immunology
Receptors, Interferon
/ genetics
Interferon gamma Receptor
Journal
Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
21
09
2018
accepted:
29
04
2019
pubmed:
27
6
2019
medline:
20
11
2019
entrez:
26
6
2019
Statut:
ppublish
Résumé
Type III interferon (IFN-λ) is important for innate immune protection at mucosal surfaces and has therapeutic benefit against influenza A virus (IAV) infection. However, the mechanisms by which IFN-λ programs adaptive immune protection against IAV are undefined. Here we found that IFN-λ signaling in dendritic cell (DC) populations was critical for the development of protective IAV-specific CD8
Identifiants
pubmed: 31235953
doi: 10.1038/s41590-019-0408-z
pii: 10.1038/s41590-019-0408-z
pmc: PMC6642690
mid: NIHMS1528211
doi:
Substances chimiques
IFNG protein, mouse
0
IL10 protein, mouse
0
Receptors, Interferon
0
Interleukin-10
130068-27-8
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1035-1045Subventions
Organisme : NIAID NIH HHS
ID : T32 AI007509
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI108765
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI083019
Pays : United States
Organisme : NIH HHS
ID : P51 OD010425
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI132962
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA032962
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118916
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127463
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI104002
Pays : United States
Références
J Immunol. 2000 Jul 1;165(1):49-58
pubmed: 10861034
J Immunol. 1997 Dec 1;159(11):5197-200
pubmed: 9548456
J Virol. 2018 Jan 2;92(2):
pubmed: 29093096
J Immunol. 2012 Sep 15;189(6):2735-45
pubmed: 22891284
J Immunol Methods. 2014 Jun;408:89-100
pubmed: 24857755
J Immunol. 1994 Feb 15;152(4):1653-61
pubmed: 8120375
J Immunol. 2008 Feb 15;180(4):2474-85
pubmed: 18250457
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20248-53
pubmed: 24277853
Immunity. 2015 Jul 21;43(1):15-28
pubmed: 26200010
PLoS Pathog. 2014 Dec 11;10(12):e1004556
pubmed: 25503988
J Exp Med. 2008 Jul 7;205(7):1635-46
pubmed: 18591411
J Virol. 2017 Mar 13;91(7):
pubmed: 28077655
Front Immunol. 2017 Dec 06;8:1707
pubmed: 29270173
Oncotarget. 2017 Jan 10;8(2):2659-2671
pubmed: 27926522
Immunity. 2007 Aug;27(2):203-13
pubmed: 17707129
J Immunol. 2014 Apr 15;192(8):3596-606
pubmed: 24646741
J Immunol. 2017 Aug 1;199(3):1012-1020
pubmed: 28637903
Elife. 2018 Apr 13;7:
pubmed: 29651984
Am J Respir Cell Mol Biol. 2017 Feb;56(2):202-212
pubmed: 27632156
MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):180-185
pubmed: 29447141
Front Immunol. 2017 Jun 30;8:749
pubmed: 28713375
J Immunol. 2001 Jun 15;166(12):7437-45
pubmed: 11390496
Curr Opin Virol. 2015 Jun;12:47-52
pubmed: 25771505
Cytokine Growth Factor Rev. 2015 Oct;26(5):579-86
pubmed: 26195434
Cell Immunol. 1978 Mar 15;36(2):345-53
pubmed: 75768
Immunity. 2017 May 16;46(5):875-890.e6
pubmed: 28514692
Immunology. 1978 Sep;35(3):503-9
pubmed: 308930
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12117-22
pubmed: 22778433
PLoS Pathog. 2011 Nov;7(11):e1002345
pubmed: 22072965
Nat Immunol. 2017 Oct;18(10):1084-1093
pubmed: 28846084
PLoS Pathog. 2013;9(11):e1003773
pubmed: 24278020
J Interferon Cytokine Res. 2010 Aug;30(8):555-64
pubmed: 20712453
PLoS Pathog. 2008 Sep 12;4(9):e1000151
pubmed: 18787692
J Virol. 2010 Jun;84(11):5670-7
pubmed: 20335250
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
PLoS One. 2009;4(1):e4204
pubmed: 19145246
EMBO Mol Med. 2011 Jun;3(6):348-61
pubmed: 21538995
PLoS One. 2008 Feb 27;3(2):e1691
pubmed: 18301768
J Virol. 2011 Jan;85(1):448-55
pubmed: 20980523
Nat Genet. 2013 Feb;45(2):164-71
pubmed: 23291588
J Immunol. 2011 Dec 1;187(11):6011-21
pubmed: 22043017
J Immunol. 2009 Oct 1;183(7):4177-81
pubmed: 19767567
J Biol Chem. 2009 Jul 31;284(31):20869-75
pubmed: 19457860
EMBO Mol Med. 2016 Sep 01;8(9):1099-112
pubmed: 27520969
Curr Opin Virol. 2011 Dec;1(6):476-86
pubmed: 22323926
Nat Immunol. 2008 Oct;9(10):1091-4
pubmed: 18800157
Sci Immunol. 2017 Dec 1;2(18):
pubmed: 29196450
Methods Mol Biol. 2015;1284:481-501
pubmed: 25757788
Nat Immunol. 2003 Jan;4(1):63-8
pubmed: 12469119
Sci Transl Med. 2015 Apr 22;7(284):284ra59
pubmed: 25904743
Immunity. 2018 Feb 20;48(2):299-312.e5
pubmed: 29396160
Curr Protoc Immunol. 2001 May;Chapter 19:Unit 19.11
pubmed: 18432752
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
Nat Immunol. 2003 Jan;4(1):69-77
pubmed: 12483210
J Exp Med. 1977 Mar 1;145(3):557-68
pubmed: 233901
Immunity. 2012 Aug 24;37(2):235-48
pubmed: 22841161
PLoS Pathog. 2018 Jan 2;14(1):e1006810
pubmed: 29293660